ロード中...
The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis
We sought to evaluate how PROMIS patient-reported outcome (PRO) measures correlated with disease characteristics in systemic light chain (AL) amyloidosis patients at diagnosis. Newly diagnosed AL patients were recruited at 2 centers (N=61). Patients completed the PROMIS Global Health v1.2, PROMIS-29...
保存先:
| 出版年: | Amyloid |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7275879/ https://ncbi.nlm.nih.gov/pubmed/31971467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13506129.2020.1713743 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|